<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00290082</url>
  </required_header>
  <id_info>
    <org_study_id>2004/055/HP</org_study_id>
    <secondary_id>French state grant</secondary_id>
    <nct_id>NCT00290082</nct_id>
  </id_info>
  <brief_title>Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients</brief_title>
  <official_title>Comparison Between Midazolam and Loxapine in the Treatment of Agitated Patients in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuroleptics are used since a long time in the management of severely agitated patients.
      Loxapine is routinely used in our country, with, to our knowledge no severe adverse event
      reported, in this indication.

      However, recently, benzodiazepines have appeared interesting in agitated patients, with the
      use of midazolam.

      The aim of this study is to compare midazolam to loxapine in the treatment of severe agitated
      patients admitted in the emergency department.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, Randomized, Double-blind, Multicenter study (20 french emergency departments)
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    2 complications with midazolam
  </why_stopped>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success of treatment at 20 min</measure>
    <time_frame>20 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success of treatment at 40 and 60 min</measure>
    <time_frame>40 and 60 mn</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Agitation level at 20,40 and 60 min</measure>
    <time_frame>20, 40 and 60mn</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for rescue medication</measure>
    <time_frame>any time</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation duration</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>treatment failure</measure>
    <time_frame>one hour after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Acute Agitated Patients</condition>
  <arm_group>
    <arm_group_label>loxapine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>agitated patients were randomly assigned either to loxapine, either to midazolam group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>midazolam is compared to loxapine in terms of efficacy and tolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>loxapine, midazolam</intervention_name>
    <description>agitated patients received loxapine 1 ml/ kg body weight ( loxapine 25mg/ml) or midazolam 1 ml/ kg body weight ( midazolam 1mg/ml) if patients were still agitated 20 min after the first treatment, they received loxapine 0.5 ml/ kg body weight ( loxapine 25mg/ml) or midazolam 0.5 ml/ kg body weight ( midazolam 1mg/ml)</description>
    <arm_group_label>loxapine</arm_group_label>
    <arm_group_label>midazolam</arm_group_label>
    <other_name>Loxapac</other_name>
    <other_name>Hypnovel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>was evaluated in patients sedated, alcohol level, blood sugar</description>
    <arm_group_label>loxapine</arm_group_label>
    <arm_group_label>midazolam</arm_group_label>
    <other_name>Loxapac</other_name>
    <other_name>Hypnovel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patient monitoring</intervention_name>
    <description>Till his coming out the emergency service, patient had an hemodynamic, respiratory and neurologic monitoring as well as an agitated score monitoring The occurence of a complication during the 15 days after leaving the emergency department was prospected.</description>
    <arm_group_label>loxapine</arm_group_label>
    <arm_group_label>midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Loxapine</intervention_name>
    <description>Loxapine 1 mL / 10 kg</description>
    <arm_group_label>loxapine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam 1 mL / 10 Kg</description>
    <arm_group_label>midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Severely agitated patients (Richard Scale over or equal to 5) between 18 and 65 years old

        Exclusion Criteria:

        Hypoglycemia hypoxemia patients with known dementia blood pressure &lt;90 mmHg known cocaine
        or amphetamine intoxication pregnancy respiratory or liver insufficiency myasthenia
        sedation before arrival to hospital
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabienne FM Moritz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Creteil</city>
        <state>Paris</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Ghps</city>
        <state>Paris</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Agen</city>
        <zip>47923</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergecy department</name>
      <address>
        <city>Argenteuil</city>
        <zip>95100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Bayeux</city>
        <zip>74401</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Bondy</city>
        <zip>93143</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Carcassonne</city>
        <zip>11890</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Dijon</city>
        <zip>11890</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Elbeuf</city>
        <zip>76503</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Kremlin Bicetre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Le Havre</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Lisieux</city>
        <zip>97223</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Montauban</city>
        <zip>82013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Pontoise</city>
        <zip>95301</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Raincy-Montfermeil</city>
        <zip>93370</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>Roanne</city>
        <zip>43328</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Department</name>
      <address>
        <city>St Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2006</study_first_submitted>
  <study_first_submitted_qc>February 9, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2006</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <name_title>CHU-Hopitaux de Rouen</name_title>
    <organization>Delegation de la recherche clinique</organization>
  </responsible_party>
  <keyword>sedation</keyword>
  <keyword>midazolam</keyword>
  <keyword>loxapine</keyword>
  <keyword>agitation</keyword>
  <keyword>emergency department</keyword>
  <keyword>toxicological analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Loxapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

